$RGNX - approaching the end of falling wedge pattern
Analysts forecast $40
Falling wedge pattern approaching it's end
Resistance 1: $13 --> R2: $16
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.50 EUR
−238.73 M EUR
81.76 M EUR
44.68 M
About REGENXBIO Inc.
Sector
CEO
Curran M. Simpson
Headquarters
Rockville
Website
Founded
2008
FIGI
BBG00B0LV7N3
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Regenxbio hits 7-month high on $1.75bn partnership with AbbVieRegenxbio hits 7-month high following $1.75bn partnership with AbbVie
REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RRGNX: REGENXBIO Inc.
2020-08-25 07:00:00
REGENXBIO Announces FDA Clearance of IND for Phase II Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Going higher - Enough cash + catalyst in 2H, 2020I strongly believe this is going higher - has cash and have good enough catalyst for 2H, 2020 for it to run up. Good luck
RGNX BTFDRGNX sold off 12% today on news of a partial clinical hold on an NVS gene therapy trial using its vector.
After reading the press release I think this was an overreaction and the stock price will bounce back swiftly into RGNX earnings catalyst on 11/08/2019. It is sold off right to the bottom of its
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange REGENXBIO INC. DL-,0001 stocks are traded under the ticker RB0.
We've gathered analysts' opinions on REGENXBIO INC. DL-,0001 future price: according to them, RB0 price has a max estimate of 49.86 EUR and a min estimate of 21.10 EUR. Watch RB0 chart and read a more detailed REGENXBIO INC. DL-,0001 stock forecast: see what analysts think of REGENXBIO INC. DL-,0001 and suggest that you do with its stocks.
Yes, you can track REGENXBIO INC. DL-,0001 financials in yearly and quarterly reports right on TradingView.
REGENXBIO INC. DL-,0001 is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
RB0 earnings for the last quarter are −1.05 EUR per share, whereas the estimation was −1.01 EUR resulting in a −4.25% surprise. The estimated earnings for the next quarter are −1.09 EUR per share. See more details about REGENXBIO INC. DL-,0001 earnings.
REGENXBIO INC. DL-,0001 revenue for the last quarter amounts to 21.73 M EUR, despite the estimated figure of 21.22 M EUR. In the next quarter, revenue is expected to reach 22.69 M EUR.
RB0 net income for the last quarter is −53.53 M EUR, while the quarter before that showed −49.47 M EUR of net income which accounts for −8.20% change. Track more REGENXBIO INC. DL-,0001 financial stats to get the full picture.
No, RB0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 28, 2025, the company has 344.00 employees. See our rating of the largest employees — is REGENXBIO INC. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENXBIO INC. DL-,0001 EBITDA is −204.11 M EUR, and current EBITDA margin is −277.93%. See more stats in REGENXBIO INC. DL-,0001 financial statements.
Like other stocks, RB0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENXBIO INC. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.